Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM(@agingdoc1):Targeting the NLRP3 inflammasome in Alzheimer’s disease: Mechanistic insights and therapeutic advances "It uncovers the inextricable role of NLRP3 inflammasome in AD pathogenesis from the preclinical and clinical evidence... It overviews the existing anti-AD agents that inhibit the NLRP3 inflammasome activation."

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM

@agingdoc1

Longevity medicine best practices | healthspan | precision medicine | bio/acc | consulting @ Connect:

Joined May 2020

100 Following 53.8K Followers

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM@agingdoc1

2026.08.24 16:11

Targeting the NLRP3 inflammasome in Alzheimer’s disease: Mechanistic insights and therapeutic advances "It uncovers the inextricable role of NLRP3 inflammasome in AD pathogenesis from the preclinical and clinical evidence... It overviews the existing anti-AD agents that inhibit the NLRP3 inflammasome activation."